SeaCrest Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $596K | Sell |
5,765
-129
| -2% | -$11.5K | 0.07% | 248 |
|
|
2026
Q1 | $423K | Sell |
5,894
-476
| -7% | -$36.7K | 0.05% | 371 |
|
|
2025
Q4 | $508K | Sell |
6,370
-127
| -2% | -$10K | 0.05% | 319 |
|
|
2025
Q3 | $500K | Sell |
6,497
-603
| -8% | -$41.3K | 0.05% | 312 |
|
|
2025
Q2 | $490K | Sell |
7,100
-1,036
| -13% | -$67.9K | 0.05% | 317 |
|
|
2025
Q1 | $551K | Buy |
8,136
+344
| +4% | +$20.6K | 0.06% | 303 |
|
|
2024
Q4 | $350K | Sell |
7,792
-4,813
| -38% | -$270K | 0.04% | 443 |
|
|
2024
Q3 | $793K | Sell |
12,605
-4,171
| -25% | -$243K | 0.09% | 232 |
|
|
2024
Q2 | $991K | Sell |
16,776
-19,851
| -54% | -$1.24M | 0.11% | 178 |
|
|
2024
Q1 | $2.92M | Sell |
36,627
-5,962
| -14% | -$455K | 0.36% | 45 |
|
|
2023
Q4 | $3.47M | Sell |
42,589
-162
| -0.4% | -$11.5K | 0.43% | 42 |
|
|
2023
Q3 | $2.98M | Sell |
42,751
-11,350
| -21% | -$804K | 0.39% | 46 |
|
|
2023
Q2 | $3.74M | Buy |
54,101
+1,392
| +3% | +$99K | 0.47% | 38 |
|
|
2023
Q1 | $3.92M | Sell |
52,709
-7,478
| -12% | -$627K | 0.53% | 33 |
|
|
2022
Q4 | $5.61M | Sell |
60,187
-1,272
| -2% | -$123K | 0.8% | 20 |
|
|
2022
Q3 | $5.86M | Sell |
61,459
-738
| -1% | -$73.1K | 0.89% | 14 |
|
|
2022
Q2 | $5.76M | Buy |
62,197
+3,727
| +6% | +$364K | 0.73% | 17 |
|
|
2022
Q1 | $5.92M | Sell |
58,470
-6,238
| -10% | -$655K | 0.68% | 19 |
|
|
2021
Q4 | $6.67M | Sell |
64,708
-5
| -0% | -$462 | 0.73% | 20 |
|
|
2021
Q3 | $5.49M | Sell |
64,713
-507
| -0.8% | -$42.5K | 0.66% | 24 |
|
|
2021
Q2 | $5.44M | Sell |
65,220
-3,168
| -5% | -$259K | 0.66% | 24 |
|
|
2021
Q1 | $5.14M | Buy |
68,388
+2,552
| +4% | +$186K | 0.68% | 24 |
|
|
2020
Q4 | $4.5M | Sell |
65,836
-900
| -1% | -$58.5K | 0.63% | 28 |
|
|
2020
Q3 | $3.9M | Sell |
66,736
-3,933
| -6% | -$245K | 0.62% | 31 |
|
|
2020
Q2 | $4.59M | Sell |
70,669
-2,934
| -4% | -$185K | 0.79% | 19 |
|
|
2020
Q1 | $4.37M | Buy |
73,603
+20,700
| +39% | +$1.38M | 0.94% | 15 |
|
|
2019
Q4 | $3.93M | Buy |
52,903
+563
| +1% | +$39.5K | 0.66% | 29 |
|
|
2019
Q3 | $3.3M | Buy |
52,340
+10,359
| +25% | +$614K | 0.62% | 34 |
|
|
2019
Q2 | $2.29M | Buy |
41,981
+16,527
| +65% | +$890K | 0.47% | 44 |
|
|
2019
Q1 | $1.37M | Buy |
25,454
+13,138
| +107% | +$811K | 0.24% | 88 |
|
|
2018
Q4 | $807K | Buy |
12,316
+2,802
| +29% | +$209K | 0.17% | 129 |
|
|
2018
Q3 | $749K | Buy |
9,514
+340
| +4% | +$24.3K | 0.13% | 164 |
|
|
2018
Q2 | $590K | Buy |
9,174
+1,935
| +27% | +$128K | 0.11% | 213 |
|
|
2018
Q1 | $450K | Buy |
7,239
+1,569
| +28% | +$113K | 0.08% | 267 |
|
|
2017
Q4 | $411K | Buy |
+5,670
| New | +$412K | 0.08% | 289 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
CGH
SeaCrest Wealth Management's CVS Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its CVS Health (CVS) stake by 2.2% in Q2 2026, selling an estimated $11.5K and leaving 5,765 shares worth $596K. The position accounts for 0.07% of the portfolio, ranked #248.
SeaCrest Wealth Management first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. The position peaked at $6.67M in Q4 2021. 459 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- SeaCrest Wealth Management held 5,765 shares of CVS Health worth $596K as of Q2 2026.
- SeaCrest Wealth Management sold 129 CVS Health shares in Q2 2026, an estimated $11.5K.
- CVS Health made up 0.07% of SeaCrest Wealth Management's portfolio in Q2 2026, its #248 holding.
- SeaCrest Wealth Management first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's CVS Health position peaked at $6.67M in Q4 2021.
- 459 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.